Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

iShares U.S. Pharmaceuticals ETF (IHE)

152.93
Delayed Data
As of Jul 26
 -0.34 / -0.22%
Today’s Change
113.55
Today|||52-Week Range
182.40
-5.42%
Year-to-Date

Investment Objective

The investment seeks to track the investment results of Dow Jones U.S. Select Pharmaceuticals Index. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. The underlying fund measures the performance of the pharmaceuticals sector of the U.S. equity market and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins. The fund is non-diversified.

Performance

1 month+10.41% 3 years+14.85%
3 months+5.19% 5 years+17.57%
1 year-13.05% Since inception+13.19%
Data through 07/26/2016

Quote Details

Previous close$153.27
Open day’s range152.60 – 153.74
Net asset value (NAV)153.19 (07/25/2016)
Daily volume8,210
Average volume (3 months)40,611
Data as of 3:59pm ET, 07/26/2016

Peer Comparisonvs. Health ETFs

 IHECategory
Performance 5-yr return+17.57%+15.32%
Expense Gross exp ratio0.43%0.47%
Risk 5 year sharpe ratio1.080.99
Net assets$621.8M$1.1B
Average market cap$18.8B$35.5B
Average P/E29.620.8
Dividend / Share--0.22%

Competitors

XLV Health Care Select Sector SPDR® Fund
VHT Vanguard Health Care Index Fund ETF Shar...
RYH Guggenheim S&P 500® Equal Weight Health...

Holdings

Top 5 Sectors
Portfolio weighting
Healthcare 98.99%
Consumer goods 1.01%
Business service 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
JNJ Johnson & Johnson10.43%
PFE Pfizer8.65%
MRK Merck7.81%
BMY Bristol-Myers Squibb7.14%
LLY Eli Lilly and Co6.24%
AGN Allergan6.11%
ZTS Zoetis Inc3.83%
MYL Mylan NV3.50%
PRGO Perrigo Company PLC3.04%
TSRO TESARO Inc2.89%

Partner Offers

Search for Jobs